logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Pfizer Tops Estimates in Second Quarter, Reiterates Full Year Outlook

By  +Follow July 30, 2013 8:52AM
Share:
Tickers Mentioned:

Pfizer Inc. (PFE) , the biggest drugmaker in the world, on Tuesday reported second-quarter earnings that nipped past analyst predictions as the company fought through declining sales that were hamstringed by the loss of exclusivity on the blockbuster cholesterol fighter Lipitor.

For the quarter, NYC-based Pfizer said it generated $12.97 billion in revenue, compared to $13.97 billion in the second quarter last year.  Net income soared to $14.1 billion, or $1.98 per share, versus $3.25 billion, or 43 cents per share, in last year’s quarter.  In February, Pfizer spun-out its animal health business into a new company called Zoetis, Inc. (ZTS) .  In December 2012, it sold its nutrition business to Nestle SA ($NSRGY) for $11.85 billion, accounting for most of the surge in reported income.  Excluding gains from the sale, restructuring costs and other special items, adjusted profits for the second quarter totaled $4.0 billion, or 56 cents per share, compared to $4.45 billion, or 59 cents per share, in the year prior quarter.

Wall Street was expecting EPS of 55 cents on revenue of $13.01 billion.

Sales of Lipitor sank 55 percent from $1.22 billion in the second quarter of 2012 to $545 million in the latest quarter.  Sales of pneumococcal vaccine Prevnar slipped 3 percent to $969 million due to changes in government purchasing patterns.  Counterbalancing those losses, sales of Pfizer’s biggest drug Lyrica, which is indicated for fibromyalgia, diabetic nerve pain and more, improved by 10 percent to $1.13 billion.

Revenue for Pfizer’s leading business units – primary care, specialty care, emerging markets and established products – all declined compared to the year prior quarter.  Ian Read, chairman and chief executive at Pfizer, said in today’s statement that he expects emerging market business growth to accelerate in the second of the year, led by China.

“From a total company view, we are tracking to our expectations for the full year and continue to capitalize on the investments we are making to better position Pfizer for long-term success,” added Read.

The company backed its 2013 forecast of adjusted earnings in the range of $2.10 to $2.20 per share.

Sales of anti-cancer drugs rose 24 percent to $399 million, boosted in part by a 191-percent climb in sales of Xalkori to $67 million and $17 million in sales from new drug Inlyta.

Operating margin improved significantly from 29.9 percent to 41.3 percent.

Marking “the next step in Pfizer’s journey to further revitalize [its] innovative core,” Pfizer said on Monday that it intends to split its company into three new units.  One unit will focus on drugs that are patent-protected beyond 2015.  The second will include vaccines, oncology and consumer healthcare products.  The third will include drugs that have lost – or will soon lose – patent exclusivity, generics and future product collaborations.  The changes are slated to start happening in January.

Two new drugs, blood thinner Eliquis and rheumatoid arthritis drug Xeljanz, are thought by many to have the capabilities to grow into blockbusters, although Zeljanz is facing some hurdles in Europe with negative opinions being offered by a European Medicines Agency committee.  Zeljanz generated $33 million in sales in the second quarter. The FDA is reviewing a supplemental New Drug Application (NDA) for Zeljanz with a decision expected by February.  Topline results are expected from two ongoing phase 3 trials evaluating Zeljanz in the second quarter next year.  The FDA is also reviewing a supplemental NDA for Eliquis, with a decision expected by March 15, 2014. 

During the second quarter, Pfizer repurchased $3.3 billion worth of its common stock, bringing its first-half total to $8.7 billion.

Shares of PFE have risen 20 percent so far in 2013 through Monday’s close at $29.54.  

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for PFE
Quantpost Healthcare
22 Sep 14 07:48:03
$PFE News Alert: http://t.co/qd5UYroBbG Updated options view: https://t.co/575GiCcS5u All options views: https://t.co/fArdRSxADp
MarketCurrents
22 Sep 14 07:48:02
Plandai firms up plans to develop horny goat week extract http://t.co/uMwg8YEVDO $PLPL $PFE $LLY $GSK
Future Tech Investor
22 Sep 14 06:18:24
$BA chart $LMT $GE $SPR $NOC $TXT $TSLA $YHOO $BABA $F $GM $S $A $X $T $GS $GPRO $MSFT $MU $JPM $BAC $FSLR $Z $V $PFE http://t.co/cm2Z9WlAUy
12Stocks.com Biotech
22 Sep 14 05:35:05
Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Su.. http://t.co/pkF0aIKwg8 $PFE #biotech #stocks
crhz1978
22 Sep 14 05:23:46
Here comes the silver surge!!!!!!!! $slv #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
Stock Wire
22 Sep 14 05:21:59
Full circle: Startup scores big deal with Pfizer — and QB3 is happy $PFE http://t.co/uKBa9N3Jwd
4-traders.com
22 Sep 14 05:05:22
Pfizer : Bristol-Myers Squibb and Pfizer Announce Charitable Donations of More Than $1 Million to Support C... http://t.co/oJOlWrxbHs $PFE
StockNews
22 Sep 14 05:03:30
$PFE - Bristol-Myers Squibb & Pfizer Announce Charitable Donations of More Than $1 Million to Support http://t.co/QBnGQR1nZw
NASDAQ
22 Sep 14 05:02:30
$PFE - Bristol-Myers Squibb & Pfizer Announce Charitable Donations of More Than $1 Million to Support http://t.co/LvobiMM0nq
4-traders.com
22 Sep 14 04:40:02
PRICE CUTS TO HIT RANBAXY, CIPLA MOST http://t.co/3jK8ZdBf5R $RANBAXY $CIPLA $CADILAHC $PFE $4568
12Stocks.com
22 Sep 14 03:01:00
Weekly Dow #Stocks Trend $DD $VZ $JNJ $T $MMM $BA $JPM $MSFT $KO $PFE $TRV $AXP $GE $PG $IBM $GS $V $UNH $MRK @ http://t.co/TvzJfd0RGT
4-traders.com
22 Sep 14 01:45:03
Guangzhou Baiyunshan Phrmcl Hldgs : Firm wins key male disorder medicine approval http://t.co/oCTdGesLqA $600332 $PFE
Dow Stocks
22 Sep 14 00:16:20
#Dow #stocks $PFE Pfizer Daily:-0.59% Weekly:3.3% YTD:0.96% Trend:93 / 100 http://t.co/eX04HByJ2u
FinGraphs
22 Sep 14 00:00:37
RT @fgusequity: $PFE Potential resume Uptrend in a consolidation period on an Investor's View : W-D-Hourly charts http://t.co/UssXzbhVTP
FinGraphs US Equity
22 Sep 14 00:00:34
$PFE Potential resume Uptrend in a consolidation period on an Investor's View : W-D-Hourly charts http://t.co/UssXzbhVTP
Biosimilarz
21 Sep 14 23:50:01
$PFE sponsored study finds access 2 cheaper versions of rituximab would increase usage in the oncology setting; http://t.co/erj4JPxl1Q (1/3)
chartguy89
21 Sep 14 23:49:04
PFE 30.40 Stock Charts $PFE Pfizer Inc. (NYSE) Last Updated: 09/22/2014 01:49:19 PFE Stock Chart - 1 Month htt http://t.co/cv0xOGn6cB
Stock_Tracker
21 Sep 14 23:41:46
Pfizer Inc (PFE) 30.40 $PFE Breast Cancer Occurs Most Often in These 5 States Sean Williams, The Motley Fool - http://t.co/gDR4q8c0s4
chartguy89
21 Sep 14 23:28:38
PFE 30.40 Stock Charts $PFE Pfizer Inc. (NYSE) Last Updated: 09/22/2014 01:28:53 PFE Stock Chart - 1 Month htt http://t.co/BNaFYrus4Y
crhz1978
21 Sep 14 19:37:25
Here comes the $slv #silver capitulation rally. Way oversold- manipulation. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 19:11:06
Here comes the $slv #silver spike!! ⤴️ #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 19:05:14
#us likely to send ground troops to fight #isis #iPhone6 $SlV $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 18:31:15
SEC to investigate #silver manipulation ???happening. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 18:12:57
@federalreserve @sec please investigate $slv #silver manipulation happening. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
crhz1978
21 Sep 14 18:11:00
@federalreserve - please investigate $slv #silver manipulation happening. #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl
BUMBLEBEECHARTS
21 Sep 14 17:48:56
$PFE Black arrow bearish outside day, ALERT! take notice. A break of 8 day ema is second warning http://t.co/MIh5AoX6DL
theoptiondon
21 Sep 14 17:30:56
$pfe low p/c ratio: 9,361 (puts) 173,889 (calls) traded Friday...1st weekly BUY signal. 32s next? http://t.co/ugqEcKu2JK
4-traders.com
21 Sep 14 14:00:02
Pfizer : Labour in Manchester Miliband has work to do, in explaining what he's all about http://t.co/BUvqjdOp6f $PFE $AZN
Stock Wire
21 Sep 14 11:26:07
Active Stocks: Pfizer Inc. (NYSE:PFE), Concur Technologies (NASDAQ:CNQR ... $PFE http://t.co/VglyMCWPc3
David Collins
21 Sep 14 10:00:18
Commented on StockTwits: Add $APRI & its rapid onset cream to male sexual health investment idea list $LLY $PFE $... http://t.co/kVEZy5aUme
G. Thomas Lackey Jr
21 Sep 14 07:56:47
The Nitrous Scan 9/19/2014 http://t.co/Dwu349assS $VDC $WNS $RDWR $WFC $QDEL $CRME $PFE $ATK $HUN $LULU
BayAreaBiotechI
20 Sep 14 18:00:20
RT @TomSilver39: UBS"Major advances in cancer therapeutics(data April 2014): $BMY $MRK $PFE $NVS $LLY …" http://t.co/OXgHogoPAb
CoachNina
20 Sep 14 15:04:56
RT @stock_coach: BIG #Money #trade #alerts $CL $HLF $JNJ $K $MMM $NUS $PG $PFE $PM @ http://t.co/ID7UtQQT2F #thecoachsroster
Investors Hangout
20 Sep 14 13:02:50
Stock Contest!! Pick $EC and WIN a FREE Tablet!! Enter NOW! Click here for details: http://t.co/TGSzjDwnvJ $BITA $VNET $INCC $PFE ~
Jon Marathon
20 Sep 14 11:10:24
RT @pharmalot: An FDA 'Revolving Door' fosters conflicts of interest on advisory panels.. details here http://t.co/7mhPj9B06k #pharma #FDA …
WinningStockCoach
20 Sep 14 11:00:00
BIG #Money #trade #alerts $CL $HLF $JNJ $K $MMM $NUS $PG $PFE $PM @ http://t.co/ID7UtQQT2F #thecoachsroster
Investors Hangout
20 Sep 14 10:21:29
DennyT: LUV Filings and Disclosure $LUV $USLV $SBUX $PFE http://t.co/vobIsOqCK2
Investors Hangout
20 Sep 14 10:21:23
DennyT: LUV Filings and Disclosure $LUV $USLV $SBUX $PFE http://t.co/d19TWRHGvC
DennyT
20 Sep 14 10:02:24
LUV Filings and Disclosure $LUV $USLV $SBUX $PFE $NEWL Buy or Sell?,Volume,Volume,Headlines,Buzz Stock Quote h http://t.co/PveGfa5tas
Heyoka;╪ͥͥͥͥͥͥͥͥͥͥͥ
20 Sep 14 10:00:25
RT @gibsonsingley: The Truth About Corporate America's Biggest Tax Dodgers http://t.co/18ohkpdwoq via @daily_finance $GE $PFE $AAPL #Renew…
Investors Hangout
20 Sep 14 09:58:20
danrocks: $BABA Making Some Noise $JCP $CVX $PFE $EEM $RSX http://t.co/dAjt3ESTcP
Investors Hangout
20 Sep 14 09:58:18
danrocks: $BABA Making Some Noise $JCP $CVX $PFE $EEM $RSX http://t.co/MOaUQ8CDfQ
Kathleen
20 Sep 14 09:56:35
The Truth About Corporate America's Biggest Tax Dodgers http://t.co/18ohkpdwoq via @daily_finance $GE $PFE $AAPL #RenewUI #fireboehner
danrocks
20 Sep 14 09:48:54
$BABA Making Some Noise $JCP $CVX $PFE $EEM $RSX http://t.co/hLlHbVGTdV
Investors Hangout
20 Sep 14 09:24:29
Emylers: $PFE Up to date company activities and other http://t.co/t94SabA7Or
Investors Hangout
20 Sep 14 09:24:22
Emylers: $PFE Up to date company activities and other http://t.co/u7JbrRf68F
Emylers
20 Sep 14 09:16:53
$PFE Up to date company activities and other important information about $PFE http://t.co/lppmYNsmR6
chartguy89
20 Sep 14 09:02:06
BBBY Stock Chart $BBBY $UNG $USO $PFE http://t.co/3UX1jBdLQX http://t.co/WcaHkQSPvZ
Investors Hangout
20 Sep 14 08:27:13
clayton: $PFE 30.4 http://t.co/VtYuljTO6q
Investors Hangout
20 Sep 14 08:27:11
clayton: $PFE 30.4 http://t.co/fAQhq69C2P
				
				
By  +Follow July 30, 2013 8:52AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.